The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Herbal bioactivation: The good, the bad and the ugly
Open accessAbstract
It has been well established that the formation of reactive metabolites of drugs is associated with drug toxicity. Similarly, there are accumulating data suggesting the role of the formation of reactive metabolites/intermediates through bioactivation in herbal toxicity and carcinogenicity. It has been hypothesized that the resultant reactive metabolites following herbal bioactivation covalently bind to cellular proteins and DNA, leading to toxicity via multiple mechanisms such as direct cytotoxicity, oncogene activation, and hypersensitivity reactions. This is exemplified by aristolochic acids present in Aristolochia spp, undergoing reduction of the nitro group by hepatic cytochrome P450 (CYP1A1/2) or peroxidases in extrahepatic tissues to reactive cyclic nitrenium ion. The latter was capable of reacting with DNA and proteins, resulting in activation of H-ras oncogene, gene mutation and finally carcinogenesis. Other examples are pulegone present in essential oils from many mint species; and teucrin A, a diterpenoid found in germander (Teuchrium chamaedrys) used as an adjuvant to slimming diets. Extensive pulegone metabolism generated p-cresol that was a glutathione depletory, and the furan ring of the diterpenoids in germander was oxidized by CYP3A4 to reactive epoxide which reacts with proteins such as CYP3A and epoxide hydrolase. On the other hand, some herbal/dietary constituents were shown to form reactive intermediates capable of irreversibly inhibiting various CYPs. The resultant metabolites lead to CYP inactivation by chemical modification of the heme, the apoprotein, or both as a result of covalent binding of modified heme to the apoprotein. Some examples include bergamottin, a furanocoumarin of grapefruit juice; capsaicin from chili peppers; glabridin, an isoflavan from licorice root; isothiocyanates found in all cruciferous vegetables; oleuropein rich in olive oil; dially sulfone found in garlic; and resveratrol, a constituent of red wine. CYPs have been known to metabolize more than 95% therapeutic drugs and activate a number of procarcinogens as well. Therefore, mechanism-based inhibition of CYPs may provide an explanation for some reported herb-drug interactions and chemopreventive activity of herbs. Due to the wide use and easy availability of herbal medicines, there is increasing concern about herbal toxicity. The safety and quality of herbal medicine should be ensured through greater research, pharmacovigilance, greater regulatory control and better communication between patients and health professionals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacological preconditioning with resveratrol: role of nitric oxide
Hattori, R., Otani, H., Maulik, N., & Das, D. K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01012.2001 · Cited by 202
RetractedFisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 2×
“Inhibition of Phase I enzymes and induction of Phase II enzymes will contribute to the chemopreventive activity of resveratrol (Dubuisson et al., 2002; Jang et al., 1997).”
BackgroundYang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
Block, G., Patterson, B., & Subar, A. (1992) · Nutrition and Cancer · doi:10.1080/01635589209514201 · Cited by 3,238
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Cytochrome P-450: Structure, Mechanism, and Biochemistry
de Montellano, O., & Paul, R. (1986) · Medical Entomology and Zoology · Cited by 2,663
Cytochrome P450: Structure, mechanism, and biochemistry
Pryor, W. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)83807-x · Cited by 1,598
Clinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet Light
Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L., & Pathak, M. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412052912301 · Cited by 1,376
Schweiger, D., Baufeld, C., Drescher, P., Oltrogge, B., Höpfner, S., Mess, A., Lüttke, J., Rippke, F., Filbry, A., & Max, H. (2013) · Skin Pharmacology and Physiology · doi:10.1159/000348473 · Cited by 1,346
Glucosinolates and their breakdown products in food and food plants
Fenwick, G. R., Heaney, R. K., Mullin, W. J., & VanEtten, C. H. (1983) · C R C Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398209527361 · Cited by 1,320
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702053160603 · Cited by 1,199
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13615-x · Cited by 1,158
Fugh-Berman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06457-0 · Cited by 1,099
Nelson, D. R. (2009) · Human Genomics · doi:10.1186/1479-7364-4-1-59 · Cited by 1,014
Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
Guengerich, F. P., & Shimada, T. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00022a001 · Cited by 1,000
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
Rendic, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 949
Dresser, G. K., Spence, J. D., & Bailey, D. G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038010-00003 · Cited by 908
(2006) · Pharmacodynamic Basis of Herbal Medicine, Second Edition · doi:10.1201/9781420006452.ch4 · Cited by 905
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., & Sutter, T. R. (1996) · PubMed · Cited by 895
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G., & Goldberg, D. M. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06045-1 · Cited by 874
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Antioxidant and other biological activities of phenols from olives and olive oil
Visioli, F., Poli, A., & Gall, C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1028 · Cited by 754
Grapefruit juice–drug interactions
Bailey, D. G., Malcolm, J., Arnold, O., & David Spence, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00764.x · Cited by 740
Major phenolic compounds in olive oil: metabolism and health effects
Tuck, K. L., & Hayball, P. J. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00229-2 · Cited by 705
Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., & Förstermann, U. (2002) · Circulation · doi:10.1161/01.cir.0000029925.18593.5c · Cited by 666
Carluccio, M. A., Siculella, L., Ancora, M. A., Massaro, M., Scoditti, E., Storelli, C., Visioli, F., Distante, A., & De Caterina, R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000062884.69432.a0 · Cited by 640
Olive-oil consumption and health: the possible role of antioxidants
Owen, R. W., Giacosa, A., Hull, W. E., Haubner, R., Würtele, G., Spiegelhalder, B., & Bartsch, H. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00015-2 · Cited by 617
Interaction of citrus juices with felodipine and nifedipine
Bailey, D., Spence, J., Munoz, C., & Arnold, J. M. O. (1991) · The Lancet · doi:10.1016/0140-6736(91)90872-m · Cited by 596
A Drug over the Millennia : Pharmacognosy, Chemistry, and Pharmacology of Licorice
SHIBATA, S. (2000) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.120.10_849 · Cited by 523
Evolution of the P450 gene superfamily:
Gonzalez, F. J., & Nebert, D. W. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90174-5 · Cited by 514
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
Arlt, V. M. (2002) · Mutagenesis · doi:10.1093/mutage/17.4.265 · Cited by 505
Toxic heavy metals and undeclared drugs in Asian herbal medicines
Ernst, E. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01972-6 · Cited by 504
Role of Human Cytochromes P450 in the Metabolic Activation of Chemical Carcinogens and Toxins
Gonzalez, F. J., & Gelboin, H. V. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539409029789 · Cited by 493
Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms.
Zhang, Y., & Talalay, P. (1994) · PubMed · Cited by 478
Antioxidants and oxidants regulated signal transduction pathways
Owuor, E. D., & Kong, A.-N. T. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01137-1 · Cited by 439
Sporn, M. B., & Suh, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.525 · Cited by 439
Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents
Visioli, F., Bellomo, G., Montedoro, G., & Galli, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05546-9 · Cited by 424
Banerjee, S., Bueso-Ramos, C., & Aggarwal, B. B. (2002) · PubMed · Cited by 423
Martinez, J., & Moreno, J. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00380-9 · Cited by 408
Interactions of Herbs with Cytochrome P450
Zhou, S., Gao, Y., Jiang, W., Huang, M., Xu, A., & Paxton, J. W. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120018248 · Cited by 397
Self-citationChristopher Gorski, J., Hall, S. D., Jones, D. R., & VandenBranden, M. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90543-6 · Cited by 395
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
Gusman, J. (2001) · Carcinogenesis · doi:10.1093/carcin/22.8.1111 · Cited by 388
Biological Properties of Olive Oil Phytochemicals
Visioli, F., & Galli, C. (2002) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690290825529 · Cited by 369
Anti-Helicobacter pylori flavonoids from licorice extract
Fukai, T., Marumo, A., Kaitou, K., Kanda, T., Terada, S., & Nomura, T. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01864-7 · Cited by 367
Herb–drug interactions: Review and assessment of report reliability
Fugh‐Berman, A., & Ernst, E. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01469.x · Cited by 364
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
MANYIKE, P., KHARASCH, E., KALHORN, T., & SLATTERY, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104736 · Cited by 355
Disposition of intravenous and oral cyclosporine after administration with grapefruit juice*
Ducharme, M. P., Warbasse, L. H., & Edwards, D. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90032-2 · Cited by 347
Cytochrome P450 phenotypic ratios for predicting herb‐drug interactions in humans
Gurley, B. J., Gardner, S. F., Hubbard, M. A., Williams, D. K., Gentry, W. B., Cui, Y., & Ang, C. Y. W. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126913 · Cited by 343
Tamoxifen for Prevention of Breast Cancer
Cersosimo, R. J. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700219 · Cited by 343
Enzymatic activation of chemicals to toxic metabolites
Guengerich, F. P., Liebler, D. C., & Reed, D. L. (1985) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448509037460 · Cited by 334
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat, K., Lantvit, D. D., Christov, K. T., Mehta, R. G., Moon, R. C., & Pezzuto, J. M. (2001) · PubMed · Cited by 330
Capsaicin, a double-edged sword: Toxicity, metabolism, and chemopreventive potential
Surh, Y.-J., & Sup Lee, S. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00159-4 · Cited by 318
Aziz, M., Kumar, R., & Ahmad, N. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.1.17 · Cited by 316
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
He, K., Iyer, K. R., Hayes, R. N., Sinz, M., Woolf, T. F., & Hollenberg, P. F. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970192k · Cited by 312
Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-11-3550 · Cited by 306
Drug–Grapefruit Juice Interactions
Kane, G. C., & Lipsky, J. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.9.933 · Cited by 301
Mechanism-based enzyme inactivation : chemistry and enzymology
Silverman, R. B. (1988) · Medical Entomology and Zoology · Cited by 299
Hydroxytyrosol Disposition in Humans
Miro-Casas, E., Covas, M.-I., Farre, M., Fito, M., Ortuño, J., Weinbrenner, T., Roset, P., & de la Torre, R. (2003) · Clinical Chemistry · doi:10.1373/49.6.945 · Cited by 295
Aristolochic Acid and ???Chinese Herbs Nephropathy???: A Review of the Evidence to Date
Cosyns, J.-P. (2003) · Drug Safety · doi:10.2165/00002018-200326010-00004 · Cited by 286
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 274
Self-citationEffects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity
Henderson, G. L., Harkey, M. R., Gershwin, M. E., Hackman, R. M., Stern, J. S., & Stresser, D. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00407-5 · Cited by 274
Schmeiser, H. H., Bieler, C. A., Wießler, M., de Strihou, C. V. Y., & Cosyns, J. P. (1996) · PubMed · Cited by 272
Adverse effects of herbal drugs in dermatology
Ernst, E. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03822.x · Cited by 272
Larrey, D., Vial, T., Pauwels, A., Castot, A., Biour, M., David, M., & Michel, H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-129 · Cited by 271
Efficacy of Kava Extract for Treating Anxiety: Systematic Review and Meta-Analysis
Pittler, M. H., & Ernst, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00014 · Cited by 267
Shimada, T., Iwasaki, M., Martin, M. V., & Guengerich, F. P. (1989) · PubMed · Cited by 265
Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil.
D’Angelo, S., Manna, C., Migliardi, V., Mazzoni, O., Morrica, P., Capasso, G., Pontoni, G., Galletti, P., & Zappia, V. (2001) · PubMed · Cited by 262
Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites
Brady, J. F., Ishizaki, H., Fukuto, J. M., Lin, M. C., Fadel, A., Gapac, J. M., & Yang, C. S. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00024a008 · Cited by 262
Anderson, I. B., Mullen, W. H., Meeker, J. E., Khojasteh-Bakht, S. C., Oishi, S., Nelson, S. D., & Blanc, P. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-8-199604150-00004 · Cited by 260
Coma from the Health Food Store: Interaction between Kava and Alprazolam
Almeida, J. C., & Grimsley, E. W. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-11-199612010-00023 · Cited by 260
Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines
Nakagawa, H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.6.891 · Cited by 256
Orallo, F., Álvarez, E., Camiña, M., Leiro, J. M., Gómez, E., & Fernández, P. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12861-1 · Cited by 250
Effect of grapefruit juice on digoxin pharmacokinetics in humans.
Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., & Funck‐Brentano, C. (2001) · PubMed · Cited by 234
Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., & Fernandez-Salguero, P. M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01296-0 · Cited by 234
The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba
Watanabe, C. M. H., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J. J., Schultz, P. G., & Gohil, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111126298 · Cited by 234
Chemoprevention of colon carcinogenesis by organosulfur compounds.
Reddy, B. S., Rao, C. V., Rivenson, A., & Kelloff, G. J. (1993) · PubMed · Cited by 222
Fitzsimmons, M. E., & Collins, J. M. (1997) · PubMed · Cited by 221
Unsafe and potentially safe herbal therapies
Klepser, T. B., & Klepser, M. E. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.2.125 · Cited by 217
Estrogen-like activity of glabrene and other constituents isolated from licorice root
Tamir, S., Eizenberg, M., Somjen, D., Izrael, S., & Vaya, J. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00093-0 · Cited by 216
Historical perspective on garlic and cardiovascular disease
Rahman, K. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.3.977s · Cited by 215
Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity
Yang, C. S., Brady, J. F., & Hong, J. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1537464 · Cited by 215
Hirsch, K., Danilenko, M., Giat, J., Miron, T., Rabinkov, A., Wilchek, M., Mirelman, D., Levy, J., & Sharoni, Y. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_14 · Cited by 212
Chili Pepper Consumption and Gastric Cancer in Mexico: A Case-Control Study
López-Carnllo, L., Avila, M. H., & Dubrow, R. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116993 · Cited by 211
Lahiri-Chatterjee, M., Katiyar, S. K., Mohan, R. R., & Agarwal, R. (1999) · PubMed · Cited by 208
Yang, C. S., Chhabra, S. K., Hong, J.-Y., & Smith, T. J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.3.1041s · Cited by 204
Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity
Zou, L., Harkey, M. R., & Henderson, G. L. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01913-6 · Cited by 204
Effect of grapefruit juice on blood cyclosporin concentration
Yee, G. C., Stanley, D. L., Pessa, L. J., Costa, T. D., Beltz, S. E., Ruiz, J., & Lowenthal, D. T. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90700-9 · Cited by 203
Afshari, C. A., Nuwaysir, E. F., & Barrett, J. C. (1999) · PubMed · Cited by 201
Volz, H.-P., & Kieser, M. (1997) · Pharmacopsychiatry · doi:10.1055/s-2007-979474 · Cited by 200
Health Risks of Herbal Remedies
De Smet, P. A. G. M. (1995) · Drug Safety · doi:10.2165/00002018-199513020-00003 · Cited by 198
Strategy and planning for chemopreventive drug development: Clinical development plans II
Kelloff, G. J., Crowell, J. A., Hawk, E. T., Steele, V. E., Lubet, R. A., Boone, C. W., Covey, J. M., Doody, L. A., Omenn, G. S., Greenwald, P., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630705 · Cited by 196
An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic.
Foster, B. C., Foster, M. S., Vandenhoek, S., Krantis, A., Budzinski, J. W., Arnason, J. T., Gallicano, K., & Choudri, S. (2001) · PubMed · Cited by 189
Stedman, C. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30104 · Cited by 188
Therapeutic Potential of Kava in the Treatment of Anxiety Disorders
Singh, Y. N., & Singh, N. N. (2002) · CNS Drugs · doi:10.2165/00023210-200216110-00002 · Cited by 187
Koh, H.-L., & Woo, S. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00001 · Cited by 185
Self-citationInhibition of Human Cytochrome P450 Activities by Kava Extract and Kavalactones
Mathews, J. M., Etheridge, A. S., & Black, S. R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1153 · Cited by 183
The metabolism of benzyl isothiocyanate and its cysteine conjugate
Brüsewitz, G., Cameron, B. D., Chasseaud, L. F., Görler, K., Hawkins, D. R., Koch, H., & Mennicke, W. H. (1977) · Biochemical Journal · doi:10.1042/bj1620099 · Cited by 176
Piver, B., Berthou, F., Dreano, Y., & Lucas, D. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00418-0 · Cited by 172
Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
Kuwajerwala, N., Cifuentes-Pagano, E., Gautam, S. C., Menon, M., Barrack, E. R., & Reddy, G. P. V. (2002) · PubMed · Cited by 171
Li, Z. G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1531 · Cited by 169
Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress
Schwedhelm, E., Maas, R., Troost, R., & B??ger, R. H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00003 · Cited by 168
Herbals, Cancer Prevention and Health
Wargovich, M. J., Woods, C., Hollis, D. M., & Zander, M. E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3034s · Cited by 167
Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells
Kuo, P.-L., Chiang, L.-C., & Lin, C.-C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02177-x · Cited by 165
Kwon, K.-B., Yoo, S.-J., Ryu, D.-G., Yang, J.-Y., Rho, H.-W., Kim, J.-S., Park, J.-W., Kim, H.-R., & Park, B.-H. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00860-7 · Cited by 162
Concise review of the cytochrome P450s and their roles in toxicology
Omiecinski, C. (1999) · Toxicological Sciences · doi:10.1093/toxsci/48.2.151 · Cited by 162
Fatal hepatitis after herbal tea
Mostefa-Kara, N., Pauwels, A., Pines, E., Biour, M., & Levy, V. (1992) · The Lancet · doi:10.1016/0140-6736(92)92209-x · Cited by 159
Resveratrol is a potent inducer of apoptosis in human melanoma cells
Niles, R. M., McFarland, M., Weimer, M. B., Redkar, A., Fu, Y.-M., & Meadows, G. G. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00676-6 · Cited by 156
Kent, U. M., Aviram, M., Rosenblat, M., & Hollenberg, P. F. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.709 · Cited by 152
Ferry‐Dumazet, H., Garnier, O., Mamani‐Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., et al. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1327 · Cited by 152
Resveratrol and Cancer: Chemoprevention, Apoptosis, and Chemoimmunosensitizing Activities
Cal, C., Garbán, H., Jazirehi, A. R., Yeh, C.-H., Mizutani, Y., & Bonavida, B. (2003) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011033353443 · Cited by 152
Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4
Chan, W. K., & Delucchi, A. B. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00888-2 · Cited by 150
Yang, C., Smith, T. J., & Hong, J. (1994) · PubMed · Cited by 147
Garlic: A review of its relationship to malignant disease
Dausch, J. G., & Nixon, D. W. (1990) · Preventive Medicine · doi:10.1016/0091-7435(90)90034-h · Cited by 145
Roche, H. M., Zampelas, A., Knapper, J. M. E., WEBB, D. H., Brooks, C., Jackson, K. G., Wright, J. W., GOULD, B. J., Kafatos, A., Gibney, M. J., et al. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.552 · Cited by 142
Yang, Y., Conaway, C. C., Chiao, J.-W., Wang, C.-X., Amin, S., Whysner, J. A., Dai, W. H., Reinhardt, J., & Chung, F. (2002) · PubMed · Cited by 141
Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs, L. L., Peter, R. M., Thompson, S. J., Rettie, A. E., & Trager, W. F. (1997) · PubMed · Cited by 140
Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse
Gordon, W. P., Forte, A. J., McMurtry, R. J., Gal, J., & Nelson, S. D. (1982) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(82)90387-8 · Cited by 139
Dietary factors and the risk of gastric cancer in Mexico city
Ward, M. H., & Lopez-Carrillo, L. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009736 · Cited by 136
In Vivo 11β-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice
Ferrari, P., Sansonnens, A., Dick, B., & Frey, F. J. (2001) · Hypertension · doi:10.1161/hy1101.096112 · Cited by 136
Kohyama, N., Nagata, T., Fujimoto, S.-I., & Sekiya, K. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.347 · Cited by 135
Reilly, C. A., Ehlhardt, W. J., Jackson, D. A., et al. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025599q · Cited by 134
Cancer chemopreventive and therapeutic activities of red ginseng
Xiaoguang, C., Hongyan, L., Xiaohong, L., Zhaodi, F., Li, Y., Lihua, T., & Han, R. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(97)00133-5 · Cited by 132
Nortier, J., & Vanherweghem, J. L. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00486-9 · Cited by 129
Lekéhal, M., Pessayre, D., Lereau, J. M., Moulis, C., Fourasté, I., & Fau, D. (1996) · Hepatology · doi:10.1002/hep.510240134 · Cited by 128
Scharf, G., Prustomersky, S., Knasmüller, S., Schulte‐Hermann, R., & Huber, W. W. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4501_9 · Cited by 127
Structural Aspects of The Inhibitory Effect of Glabridin on LDL Oxidation
Belinky, P. A., Aviram, M., Mahmood, S. A., & Vaya, J. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00006-9 · Cited by 124
Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes
Fau, D., Lekéhal, M., Farrell, G. C., Moreau, A., Moulis, C., Feldmann, G., Haouzi, D., & Pessayre, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322529 · Cited by 120
Landrault, N., Larronde, F., Delaunay, J.-C., Castagnino, C., Vercauteren, J., Mérillon, J., Gasc, F., Cros, G. H., & Teissèdre, P. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010794g · Cited by 120
Hepatotoxicity of germander in mice
Loeper, J., Descatoire, V., Lettéron, P., Moulis, C., Degott, C., Dansette, P. M., Fau, D., & Pessayre, D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90606-8 · Cited by 119
Stiborová, M., Frei, E., Wießler, M., & Schmeiser, H. H. (2001) · Chemical Research in Toxicology · doi:10.1021/tx010059z · Cited by 119
Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
Schmeiser, H. H., Janssen, J. W. G., Lyons, J., Scherf, H. R., Pfau, W., Buchmann, A., Bartram, C. R., & Wießler, M. (1990) · PubMed · Cited by 117
El‐Mowafy, A. M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg015 · Cited by 117
Levenson, A. S., Gehm, B. D., Pearce, S. T., Horiguchi, J., Simons, L. A., Ward, J. E., Jameson, J. L., & Jordan, V. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.10992 · Cited by 115
Koenigs, L. L., & Trager, W. F. (1998) · Biochemistry · doi:10.1021/bi981198r · Cited by 115
Mueller, S. O., Kling, M., Firzani, P. A., Mecky, A., Duranti, E., Shields-Botella, J., Delansorne, R., Broschard, T. H., & Kramer, P.-J. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00016-x · Cited by 115
Piver, B., Berthou, F., Dréano, Y., & Lucas, D. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00420-x · Cited by 115
Psoralen Photochemotherapy of Cutaneous Disorders
Anderson, T. F., & Voorhees, J. J. (1980) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.20.040180.001315 · Cited by 112
Rosenblat, M., Belinky, P. A., Vaya, J., Lévy, R., Hayek, T., Coleman, R., Merchav, S., & Aviram, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13790 · Cited by 110
Mechanism-Based Inactivation of P450 2A6 by Furanocoumarins
Koenigs, L. L., & Trager, W. F. (1998) · Biochemistry · doi:10.1021/bi980003c · Cited by 110
Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
Wagatsuma, S., Konno, R., Sato, S., & Yajima, A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980201)82:3<448::aid-cncr4>3.0.co;2-l · Cited by 108
Liang, Y., Tsai, S., Chen, L., Lin‐Shiau, S., & Lin, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00011-x · Cited by 108
A Systematic Review of the Safety of Kava Extract in the Treatment of Anxiety
Stevinson, C. D., Huntley, A. L., & Ernst, E. (2002) · Drug Safety · doi:10.2165/00002018-200225040-00003 · Cited by 107
Hirose, M., Yamaguchi, T., Kimoto, N., Ogawa, K., Futakuchi, M., Sano, M., & Shirai, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<773::aid-ijc17>3.0.co;2-2 · Cited by 105
Kessler, D. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006083422309 · Cited by 104
Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats.
Ramaiah, S. K., Apte, U. M., & Mehendale, H. M. (2001) · PubMed · Cited by 103
Zheng, S. S., Yang, H., Zhang, S., Wang, X., Yu, L., Lu, J., & Li, J. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1997)27+<106::aid-jcb17>3.0.co;2-l · Cited by 102
Guyonnet, D., Belloir, C., Suschetet, M., Siess, M. H., & Bon, A. L. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00205-4 · Cited by 100
Hypersensitivity Myocarditis Associated with Ephedra Use
Zaacks, S. M., Klein, L. W., Tan, C. D., Rodríguez, E. R., Leikin, J. B., & Leikin, J. B. (1999) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-100102440 · Cited by 98
Fujisawa, Y., Sakamoto, M., Matsushita, M., Fujita, T., & Nishioka, K. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02566.x · Cited by 97
Briante, R., Cara, F. L., Tonziello, M. P., Febbraio, F., & Nucci, R. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf001342r · Cited by 94
Hepatitis after the use of germander, a herbal remedy.
Laliberté, L., & Villeneuve, J. (1996) · PubMed · Cited by 91
de Berardinis, V., Moulis, C., Maurice, M., Beaune, P. H., Pessayre, D., Pompon, D., & Loeper, J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.3.542 · Cited by 91
Resveratrol Modulates Arachidonic Acid Release, Prostaglandin Synthesis, and 3T6 Fibroblast Growth
Moreno, J. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39074-3 · Cited by 89
Stiborová, M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.617 · Cited by 88
Yang, S., Kim, J., Oh, T., Kim, M. S., Lee, S., Woo, S., Cho, H. S., Choi, Y. H., Kim, Y., Rha, S. Y., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.741 · Cited by 84
Chinese Herbal Medicine Induced Acute Renal Failure
Abt, A. B., Oh, J. Y., Huntington, R. A., & Burkhart, K. K. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430020103013 · Cited by 84
HALLER, C. A., & Benowitz, N. L. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00235-5 · Cited by 84
Cresol Isomers: Comparison of Toxic Potency in Rat Liver Slices
Thompson, D. C., Perera, K., Fisher, R., et al. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1048 · Cited by 83
Estrogenic Activity in White and Red Wine Extracts
Klinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., & Jungbauer, A. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0259821 · Cited by 83
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
Gorski, J. C., Jones, D. R., Hamman, M. A., Wrighton, S. A., & Hall, S. D. (1999) · Xenobiotica · doi:10.1080/004982599238173 · Cited by 82
Hepatitis associated with Chinese herbs
Mcrae, C., Agarwal, K., Mutimer, D. J., & Bassendine, M. F. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200205000-00015 · Cited by 80
Osawa, Y., & Pohl, L. R. (1989) · Chemical Research in Toxicology · doi:10.1021/tx00009a001 · Cited by 79
Prospects for chemoprevention of cancer
Tamimi, R. M., Λάγιου, Π., Adami, H., & Trichopoulos, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00969.x · Cited by 78
Ishizaki, H., Brady, J. F., Ning, S. M., & Yang, C. S. (1990) · Xenobiotica · doi:10.3109/00498259009046845 · Cited by 77
Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta™Mouse)
Kohara, A., Suzuki, T., Honma, M., Ohwada, T., & Hayashi, M. (2002) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00350-3 · Cited by 76
Gohil, K., Moy, R. K., Farzin, S., Maguire, J. J., & Packer, L. (2000) · Free Radical Research · doi:10.1080/10715760000301351 · Cited by 75
Forging the links between metabolism and carcinogenesis
Guengerich, F. P. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(01)00059-x · Cited by 75
Teyssier, C., Guenot, L., Suschetet, M., & Siess, M. H. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)11821-1 · Cited by 74
Effects of isothiocyanates on tumorigenesis by benzo[a]pyrene in murine tumor models
Lin, J.-M., Amin, S., Trushin, N., et al. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90237-4 · Cited by 74
Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives
Tinel, M., Belghiti, J., Descatoire, V., Amouyal, G., Lettéron, P., Genève, J., Larrey, D. G., & Pessayre, D. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90190-0 · Cited by 74
Inhibition of Serotonin Re-Uptake by Licorice Constituents
Ofir, R., Tamir, S., Khatib, S., & Vaya, J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:135 · Cited by 74
POSITIVE INTERACTION OF ETHANOL AND KAVA RESIN IN MICE
Jamieson, D., & Duffield, P. H. (1990) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1990.tb01350.x · Cited by 73
Haber, D., Siess, M., Lavier, M.-C. C., et al. (1995) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399509531971 · Cited by 70
Approaches to Chemoprevention of Lung Cancer Based on Carcinogens in Tobacco Smoke
Hecht, S. S. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s4955 · Cited by 69
Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphides
Haber, D., Siess, M. H., de Waziers, I., Beaune, P. H., & Suschetet, M. (1994) · Xenobiotica · doi:10.3109/00498259409043230 · Cited by 67
New Treatment for Chronic Myelogenous Leukemia
Schwetz, B. A. (2001) · JAMA · doi:10.1001/jama.286.1.35 · Cited by 67
Inhibition of Cytochrome P450 3A4 by Extracts and Kavalactones of Piper methysticum (Kava-Kava)
Unger, M., Holzgrabe, U., Jacobsen, W., Cummins, C. L., & Benet, L. Z. (2002) · Planta Medica · doi:10.1055/s-2002-36360 · Cited by 66
The effect of garlic extract on human metabolism of acetaminophen.
Gwilt, P. R., Lear, C. L., Tempero, M. A., Birt, D. D., Grandjean, A. C., Ruddon, R. W., & Nagel, D. L. (1994) · PubMed · Cited by 66
Castot, A., & Larrey, D. G. (1992) · PubMed · Cited by 63
The basis for the chemopreventive action of resveratrol
Roemer, K., & Mahyar-Roemer, M. (2002) · Drugs of today · doi:10.1358/dot.2002.38.8.820097 · Cited by 61
Schmeiser, H. H., Scherf, H. R., & Wießler, M. (1991) · Cancer Letters · doi:10.1016/0304-3835(91)90178-k · Cited by 57
Polymeros, D., Kamberoglou, D. K., & Tzias, V. D. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200201000-00022 · Cited by 55
Stress‐induced insomnia treated with kava and valerian: singly and in combination
Wheatley, D. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.299 · Cited by 55
The 1994 Bernard B. Brodie Award Lecture. Structure, mechanism, and inhibition of cytochrome P450.
de Montellano, P. R. O. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06813-8 · Cited by 50
Alterations in hepatic Phase I and Phase II biotransformation enzymes by garlic oil in rats
Dalvi, R. R. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90288-u · Cited by 47
NSAIDs and Gastrointestinal Cancer Prevention
Jolly, K. B., Cheng, K. K., & Langman, M. J. S. (2002) · Drugs · doi:10.2165/00003495-200262060-00006 · Cited by 45
Wang, B. H., Zuzel, K. A., Rahman, K., & Billington, D. (1999) · Toxicology · doi:10.1016/s0300-483x(99)00004-9 · Cited by 44
[Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases].
Yahia, M. B., Mavier, P., Métreau, J., Zafrani, E., Fabrè, M., Gatineau-Sailliant, G., Dhumeaux, D., & Mallat, A. (1993) · PubMed · Cited by 43
(2001) · PubMed · Cited by 43
Breast cancer prevention: present and future
Salih, A. K., & Fentiman, I. S. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2001.0235 · Cited by 40
Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
Sigusch, H. H., Henschel, L., Kraul, H., Merkel, U., & Hoffmann, A. (1994) · PubMed · Cited by 40
Clinical and laboratory investigations in herbal poisonings
Deng, J. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00484-5 · Cited by 39
Park, K.-K., Chun, K., Yook, J. I., & Surh, Y. (1998) · PubMed · Cited by 38
Ernst, E., & Pittler, M. H. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00077-4 · Cited by 38
The mechanism of inhibition of cytochrome P450IIE1 by dihydrocapsaicin
Gannett, P. M., Iversen, P. L., & Lawson, T. A. (1990) · Bioorganic Chemistry · doi:10.1016/0045-2068(90)90041-3 · Cited by 37
Tsarbopoulos, A., Gikas, E. E., Papadopoulos, N. T., Aligiannis, N., & Kafatos, A. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00905-4 · Cited by 33
Gohil, K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01163-2 · Cited by 27
Cited by
Biological effects of essential oils—A review
Bakkali, F., Averbeck, S., Averbeck, D., & Idaomar, M. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.106 · Cited by 7,929
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism
Moon, Y. J., Wang, X., & Morris, M. E. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.06.048 · Cited by 869
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Herb and supplement use in the US adult population
Kennedy, J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.004 · Cited by 340
Metadata
- Authors
- Zhou, S., Koh, H.-L., Gao, Y., Gong, Z.-Y., & Lee, E. J. D.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 74
- Issue
- 8
- Pages
- 935-968
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2168566222
- Cited by
- 256
- References
- 210
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.